Loading...

Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes

Objective: To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Methods: Participants (N = 105, ages 7–13 years, mean age 10.8 ± 1.8 years) were enrolled at nine centers (eight in the United States and one in Israel) an...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Technol Ther
Main Authors: Forlenza, Gregory P., Pinhas-Hamiel, Orit, Liljenquist, David R., Shulman, Dorothy I., Bailey, Timothy S., Bode, Bruce W., Wood, Michael A., Buckingham, Bruce A., Kaiserman, Kevin B., Shin, John, Huang, Suiying, Lee, Scott W., Kaufman, Francine R.
Format: Artigo
Sprog:Inglês
Udgivet: Mary Ann Liebert, Inc., publishers 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6350071/
https://ncbi.nlm.nih.gov/pubmed/30585770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2018.0264
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!